Partial Charge Calculation Method Affects CoMFA QSAR Prediction Accuracy
暂无分享,去创建一个
Lisa Harris | Michael J. Sorich | Ross A. McKinnon | Ruchi R. Mittal | R. Mckinnon | M. Sorich | R. Mittal | Lisa Harris
[1] S. Roberts,et al. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics , 2001, Xenobiotica; the fate of foreign compounds in biological systems.
[2] Laura Belvisi,et al. A 3 D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists , .
[3] Renxiao Wang,et al. All-Orientation Search and All-Placement Search in Comparative Molecular Field Analysis , 1998 .
[4] Jonathan D. Hirst,et al. On the Stability of CoMFA Models , 2004, J. Chem. Inf. Model..
[5] Rahul Jain,et al. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents. , 2006, Bioorganic & medicinal chemistry.
[6] Tudor I. Oprea,et al. A Different Method for Steric Field Evaluation in CoMFA Improves Model Robustness , 1997, J. Chem. Inf. Comput. Sci..
[7] Jyrki Taskinen,et al. CoMFA Modeling of Human Catechol O-Methyltransferase Enzyme Kinetics. , 2004 .
[8] Ronan Bureau,et al. Conformational Analysis and 3D QSAR Study on Novel Partial Agonists of 5‐HT3 Receptors , 1996 .
[9] A. Poso,et al. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. , 1996, European journal of pharmacology.
[10] Ettore Novellino,et al. A Critical Review of Recent CoMFA Applications , 1998 .
[11] Klaus R. Liedl,et al. Different electrostatic descriptors in comparative molecular field analysis: A comparison of molecular electrostatic and coulomb potentials , 1996, Journal of Computational Chemistry.
[12] Yong-Jun Jiang,et al. 3D QSAR for GSK-3β inhibition by indirubin analogues , 2006 .
[13] G. Narahari Sastry,et al. Understanding the structural requirements of triarylethane analogues towards PDE-IV inhibitors : A molecular modeling study , 2006 .
[14] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[15] G R Marshall,et al. Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules. , 1993, Journal of medicinal chemistry.
[16] J. Sutherland,et al. A comparison of methods for modeling quantitative structure-activity relationships. , 2004, Journal of medicinal chemistry.
[17] Edmund K. Burke,et al. Exploring Phase-Transfer Catalysis with Molecular Dynamics and 3D/4D Quantitative Structure-Selectivity Relationships , 2005, J. Chem. Inf. Model..
[18] Robert D. Clark,et al. Boosted leave-many-out cross-validation: the effect of training and test set diversity on PLS statistics , 2003, J. Comput. Aided Mol. Des..
[19] Xin Hu,et al. Molecular docking and 3D-QSAR studies of Yersinia protein tyrosine phosphatase YopH inhibitors. , 2005, Bioorganic & medicinal chemistry.
[20] T R Stouch,et al. Three-dimensional quantitative structure-activity relationships of sulfonamide endothelin inhibitors. , 1995, Journal of medicinal chemistry.
[21] Juan M. Luco,et al. QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT Derivatives , 1997, J. Chem. Inf. Comput. Sci..
[22] R. Shoemaker,et al. A Three-Dimensional Quantitative Structure-Activity Relationship Study of the Inhibition of the ATPase Activity and the Strand Passing Catalytic Activity of Topoisomerase IIα by Substituted Purine Analogs , 2006, Molecular Pharmacology.
[23] Gerhard Klebe,et al. A 3D QSAR Study on a Set of Dopamine D4 Receptor Antagonists , 2003, J. Chem. Inf. Comput. Sci..
[24] Yun Tang,et al. Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists. , 2006, Bioorganic & medicinal chemistry.
[25] Wesley Schaal,et al. Improved CoMFA Modeling by Optimization of Settings , 2006, J. Chem. Inf. Model..
[26] Shagufta,et al. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents , 2007, Journal of molecular modeling.
[27] Maurizio Recanatini,et al. Comparative molecular field analysis of non-steroidal aromatase inhibitors related to fadrozole , 1996, J. Comput. Aided Mol. Des..
[28] Edmund K. Burke,et al. Exploring Phase‐Transfer Catalysis with Molecular Dynamics and 3D/4D Quantitative Structure—Selectivity Relationships. , 2005 .
[29] Carlo Scolastico,et al. A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists , 1996, J. Comput. Aided Mol. Des..
[30] Tommi H. Nyrönen,et al. Comparing the Quality and Predictiveness between 3D QSAR Models Obtained from Manual and Automated Alignment , 2004, J. Chem. Inf. Model..
[31] Yoshiaki Nakagawa,et al. Classical and three-dimensional QSAR for the inhibition of [3H]ponasterone A binding by diacylhydrazine-type ecdysone agonists to insect Sf-9 cells. , 2005, Bioorganic & medicinal chemistry.
[32] Lirong Chen,et al. Mapping the Binding Site of a Large Set of Quinazoline Type EGF-R Inhibitors Using Molecular Field Analyses and Molecular Docking Studies. , 2003 .
[33] W Welch,et al. Structural determinants of high-affinity binding of ryanoids to the vertebrate skeletal muscle ryanodine receptor: a comparative molecular field analysis. , 1994, Biochemistry.
[34] Michael J. Sorich,et al. Systematic Statistical Comparison of Comparative Molecular Similarity Indices Analysis Molecular Fields for Computer-Aided Lead Optimization. , 2006 .
[35] Antti Poso,et al. 3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. , 2006, Journal of medicinal chemistry.
[36] Marjana Novic,et al. Variable Selection and Interpretation in Structure-Affinity Correlation Modeling of Estrogen Receptor Binders , 2005, J. Chem. Inf. Model..
[37] Hongbin Yuan,et al. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment. , 2004, Journal of medicinal chemistry.
[38] A. Poso,et al. Comparative Molecular Field Analysis (CoMFA) of MX Compounds using different Semi-empirical Methods: LUMO Field and its Correlation with Mutagenic Activity , 1996 .
[39] Eric Oldfield,et al. Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates. , 2006, Journal of medicinal chemistry.
[40] Supa Hannongbua,et al. Comparative Molecular Field Analysis of HIV‐1 Reverse Transcriptase Inhibitors in the Class of 1[(2‐Hydroxyethoxy)‐methyl]‐6‐(phenylthio)thymine , 1996 .
[41] Seung Joo Cho,et al. Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Index Analysis (CoMSIA) Study of Mutagen X , 2004 .
[42] H. Koh,et al. The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA. , 2003, Bioorganic & medicinal chemistry.
[43] Tommi H. Nyrönen,et al. A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods , 2003, J. Comput. Aided Mol. Des..
[44] Roberts Sa,et al. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. , 2001 .